Monthly cost of Bosentan after enrolling in medical insurance

Bosentan (Bosentan), a prescription drug for pulmonary hypertension and chronic thrombotic microangiopathy, has attracted widespread attention in the medical community for its unique pharmacological mechanism. Clinically, bosentan is mainly used to treat pulmonary arterial hypertension, which can improve patients' activity tolerance and quality of life. Bosentan also has significant therapeutic effects on chronic thrombotic microangiopathy. Due to its anticoagulant effect, bosentan can promote blood circulation and aid recovery.

After bosentan enters the medical insurance, the monthly cost will vary according to the medical insurance policies of different regions, reimbursement ratios, individual dosage and other factors. Therefore, it is impossible to give a uniform monthly cost figure.

Generally speaking, medical insurance will reimburse a certain percentage of high-priced drugs such as bosentan, thereby reducing the financial burden on patients. However, specific reimbursement ratios and limits will vary depending on regions and medical insurance policies. In addition, patients are responsible for a portion of their out-of-pocket costs, which also affects the actual monthly cost.

Currently, bosentan tablets have been launched in the country and have been successfully included in medical insurance reimbursement items. Its specification is 56 tablets of 125mg, and the price after medical insurance reimbursement is about 3,000 yuan. At the same time, we also learned that Indian cipla pharmaceuticals has launched a generic version of bosentan overseas, with a specification of 125ng and 20 tablets, and a price of about 400 yuan. In addition, the generic version of bosentan launched overseas is also well received by patients, and patients can flexibly choose according to their own conditions. Patients can calculate their monthly expenses based on their usage and the price after local medical insurance reimbursement.